Get Free Delivery With No Minimum Order

MEBAGEN SR 200/MG CAP 30/CAP
- Sku : I-029545
Key features
MEBAGEN SR 200 mg Capsule is a sustained-release capsule containing mebeverine hydrochloride 200 mg. It is a musculotropic antispasmodic and anticholinergic‑sparing smooth muscle relaxant that directly relaxes gastrointestinal smooth muscle with minimal effect on normal motility, likely through modulation of smooth‑muscle ion fluxes. It is indicated for symptomatic relief of abdominal pain, cramps and intestinal spasm associated with irritable bowel syndrome and other functional gastrointestinal disorders. Available as prescription sustained‑release capsules in packs of 30.- Brand: MEBAGEN
- Active Ingredient: MEBEVERINE HYDROCHLORIDE 200mg
- Strength: 200mg
- Dosage Form: Capsule
- Pack Size: 30 Capsules
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Gastrointestinal
- Pharmacological Group: Antispasmodics
- Drug Class: Musculotropic Antispasmodic (Anticholinergic-sparing smooth muscle relaxant)
- Manufacturer: RIYADH PHARMA
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 1211246197
- Shelf Life: 24 months
- Storage: store below 30°c
- Gi Condition: IBS
Indications
Approved Uses
Symptomatic treatment of irritable bowel syndrome (IBS) and other functional gastrointestinal disorders associated with abdominal pain, cramps, and intestinal spasm.
Off-Label Uses
Not routinely recommended off‑label; occasionally used in practice for other functional GI spasm syndromes, but evidence is limited and should be clinician-directed.
Dosage & Administration
Dosing by Condition
Adults (IBS/functional GI spasm): 200 mg sustained‑release capsule orally twice daily (morning and evening), preferably ~20 minutes before meals.
Initial Dose
One 200mg capsule twice daily.
Maintenance Dose
200mg SR capsule twice daily (400mg/day total)
Maximum Dose
400mg per day (as 200mg twice daily).
Children's Dosage
Not recommended for children and adolescents below 18 years of age due to insufficient data on safety and efficacy.
How to Take
Swallow the sustained‑release capsule whole with water; do not crush, chew, or open; take preferably about 20 minutes before meals (e.g., morning and evening).
Side Effects
Common Side Effects
Generally uncommon; may include nausea/dyspepsia, dizziness or headache, and hypersensitivity reactions such as skin rash/urticaria (rarely angioedema).
Side Effect Frequency
Hypersensitivity reactions (rash, urticaria, angioedema, anaphylaxis) are rare; other adverse effects are generally uncommon and not consistently reported as ‘common’ at 1-10%.
Safety & Warnings
Contraindications
Hypersensitivity to mebeverine hydrochloride or to any excipient.
Age Restriction
Not recommended under 18 years.
Driving Warning
Safe
Drug Interactions
Drug Interactions
No clinically significant drug interactions are known/expected.
Interaction Severity
No clinically significant drug-drug interactions are well documented; routine interaction screening is still advised.
Special Populations
Children
Not recommended for children and adolescents below 18 years of age due to insufficient data on safety and efficacy.
Storage & Patient Advice
Stopping the Medicine
May be stopped when symptoms resolve; no taper is required.
Monitoring Requirements
No routine monitoring required.
Pharmacology
Mechanism of Action
Musculotropic antispasmodic that directly relaxes gastrointestinal smooth muscle (antispasmodic effect) with minimal effect on normal motility; the precise molecular mechanism is not fully established (proposed effects include modulation of smooth‑muscle ion fluxes).
Duration of Effect
Approximately 12 hours per SR dose (supports twice‑daily dosing).
Half-Life
Parent mebeverine has a short apparent half‑life (about 1-2 hours); the main metabolite (DMAC) has an elimination half‑life around 2.5 hours (reported ~2.45 h).
Product Information
Available Dosage Forms
For this SFDA-registered product: sustained‑release oral capsule (200 mg) in blister pack of 30 capsules.
Composition per Dose
Each sustained-release capsule: 200mg mebeverine hydrochloride
Generic Availability
Yes
Gi Condition
IBS
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)





